WHO WE ARE

Telea Electronic Engineering srl is a modern and dynamic Company that has established itself as a leader in the research, design, production and sale of innovative Electromedical devices.

Founded in Sandrigo (Vicenza) in 1988 by the brothers Arnaldo and Gianantonio Pozzato, it has consolidated its presence in national and international markets through constant and continuous growth. Nowadays Telea is present with its products in over 20 countries.

During the years, Telea has given rise to three new spin-offs.

In 2011 Telea Biotech was founded; it is a Company focused on the research and development of products in the field of tissue engineering. Telea Biotech’s researches aim to the creation of biological tissues that can be surgically implanted on patients. Among these, research has focused particularly on the regeneration of the oesophagus. The studies on the oesophagus, which are giving excellent results, are performed in collaboration with the Hospital Gemelli and the Hospital Bambin Gesù, both located in Rome.

On 2013 was founded NSII, based in San Diego (California), with the purpose to develop the sales in USA market.

Resono Oftalmic was founded on 2014. After a long scientific research conducted with high-level professionals and with the University of Verona, the Medical Device has been certified for the therapy of dry-eye disease. The clinical studies have shown the great effectiveness of the use of QMR, also on this of pathology.

The QMR technology used on all Telea’s Medical Devices has been tested for biological safety. A research conducted on 28,000 genes (Study conducted by the Advanced Cell Therapies Laboratory of the San Bortolo Foundation of Vicenza and the CIBIO of the University of Trento) has confirmed the efficacy regarding regeneration and the biological safety, ensured by the absence of any cellular damage.

SCIENTIFIC STUDIES AND COLLABORATIONS

  • Department of Anatomy and Human Physiology of the University of Padua
  • Department of Information Engineering of the University of Padua
  • Department of Pharmaceutical Sciences of the University of Padua
  • VIMM (Veneto Institute of Molecular Medicine)
  • City University of Health and Science of Turin
  • University of Turin Le Molinette
  • Advanced Cell Therapy Laboratory in Vicenza – San Bortolo Hospital
  • University of CIBIO in Trento
  • Fatebenefratelli Foundation in Rome